BSBMTCT Strategic Review Survey 2024

The BSBMTCT is keen to maximise its sustainability, value and impact for the BMT and cell therapy community; policymakers; commissioners, and patients – both now and in the future. It is currently undertaking a strategic review which aims to identify opportunities and risks in the Society’s operating environment, as well as appraise BSBMTCT’s functions, resources and services to understand what’s going well and where there is room for improvement.

As part of this process, the BSBMTCT is engaging a range of stakeholders – including the Executive; members; the wider clinical community; partners; policymakers and commissioners – to gather insight, ideas and perspectives.

We would very much value your help in answering the following questions for us. Your responses will be confidential and the subsequent analysis will be anonymised.

Thank you for your help.